Literature DB >> 2993407

Effects of etomidate on cortisol biosynthesis in isolated guinea-pig adrenal cells: comparison with metyrapone.

R De Coster, D Beerens, C Haelterman, L Wouters.   

Abstract

The effects of the iv hypnotic etomidate on cortisol biosynthesis have been investigated in short term incubations of dispersed guinea-pig adrenal cells and were compared with those produced by metyrapone. Fifty percent inhibition of cortisol output was obtained at a final medium concentration of 3.5 10(-8) M (basal), 2.8 10(-8) M (ACTH-stimulated) for etomidate and of 5.10(-7) M (stimulated) for metyrapone. In the presence of etomidate, 11-deoxycortisol at 5.10(-8) M reached a peak value of 244 +/- 11% of control (mean +/- SE, n = 7). 17 alpha-Hydroxyprogesterone and progesterone were not significantly affected up to 10(-7) M, but at higher concentrations, all three precursors fell under their control values. Metyrapone induced a progressive rise of 11-deoxycortisol, from 10(-7) M upwards, to a maximum level at 10(-5) M (210 +/- 15% of control, mean +/- SE, n = 5). 17-Hydroxyprogesterone and progesterone concentrations were not significantly modified by metyrapone. The less active hypnotic L-enantiomer of etomidate had almost no inhibitory effect on cortisol production. The results obtained so far suggest that etomidate is a potent inhibitor of the mitochondrial cytochrome P-450 enzymes of the adrenal cortex, mainly the 11 beta-hydroxylase. At higher dose the cholesterol side-chain cleavage enzyme system seemed also to be affected.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2993407     DOI: 10.1007/BF03348477

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  18 in total

1.  Effects of etomidate on steroid biosynthesis in subcellular fractions of bovine adrenals.

Authors:  H Vanden Bossche; G Willemsens; W Cools; D Bellens
Journal:  Biochem Pharmacol       Date:  1984-12-01       Impact factor: 5.858

2.  The inhibition by etomidate of the 11 beta-hydroxylation of cortisol.

Authors:  D E Fry; H Griffiths
Journal:  Clin Endocrinol (Oxf)       Date:  1984-05       Impact factor: 3.478

3.  Effect of etomidate on cortisol biosynthesis: site of action after induction of anaesthesia.

Authors:  R De Coster; J H Helmers; H Noorduin
Journal:  Acta Endocrinol (Copenh)       Date:  1985-12

4.  [Radioimmunoassay of bovine serum progesterone].

Authors:  J F Beckers; P Ballman; F Ectors; J Derivaux; M Herlant
Journal:  C R Acad Hebd Seances Acad Sci D       Date:  1975-01-20

5.  Etomidate: a selective adrenocortical 11 beta-hydroxylase inhibitor.

Authors:  H G Dörr; U Kuhnle; H Holthausen; F Bidlingmaier; D Knorr
Journal:  Klin Wochenschr       Date:  1984-11-02

6.  Etomidate inhibits adrenocortical function in surgical patients.

Authors:  R L Wagner; P F White
Journal:  Anesthesiology       Date:  1984-12       Impact factor: 7.892

7.  Etomidate suppresses adrenocortical function by inhibition of 11 beta-hydroxylation.

Authors:  F H de Jong; C Mallios; C Jansen; P A Scheck; S W Lamberts
Journal:  J Clin Endocrinol Metab       Date:  1984-12       Impact factor: 5.958

8.  Effects of etomidate on hormonal responses to surgical stress.

Authors:  R J Fragen; C A Shanks; A Molteni; M J Avram
Journal:  Anesthesiology       Date:  1984-12       Impact factor: 7.892

9.  Cortisol production by cells isolated from the outer and inner zones of the adrenal cortex of the guinea pig.

Authors:  T Nishikawa; C A Strott
Journal:  Endocrinology       Date:  1984-02       Impact factor: 4.736

10.  Mortality amongst multiple trauma patients admitted to an intensive therapy unit.

Authors:  I Watt; I M Ledingham
Journal:  Anaesthesia       Date:  1984-10       Impact factor: 6.955

View more
  3 in total

1.  Missing effect of etomidate on testosterone secretion in man.

Authors:  B Allolio; R Stuttmann; W Winkelmann
Journal:  Klin Wochenschr       Date:  1986-01-15

2.  11β-Hydroxylase inhibitors protect against seizures in mice by increasing endogenous neurosteroid synthesis.

Authors:  Rafal M Kaminski; Michael A Rogawski
Journal:  Neuropharmacology       Date:  2011-03-31       Impact factor: 5.250

3.  Nonhypnotic low-dose etomidate for rapid correction of hypercortisolaemia in Cushing's syndrome.

Authors:  B Allolio; H M Schulte; D Kaulen; M Reincke; C Jaursch-Hancke; W Winkelmann
Journal:  Klin Wochenschr       Date:  1988-04-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.